Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2000 of 3284 entries
View as:

Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea

Phase: N/A Priority: Normal
NCT ID: NCT02471404 Org: User:
Start: 09/21/15 End: 03/13/17 Due: 03/13/18

Observational Retrospective Study on Clinical Outcomes of Patients Receiving Benralizumab in Spain.

Phase: N/A Priority: Normal
NCT ID: NCT04648839 Org: User:
Start: 02/16/21 End: 07/16/21 Due: 07/16/22

CorRELation Between PatIent PErception and Findings on Clinical Examination

Phase: N/A Priority: Normal
NCT ID: NCT01627743 Org: User:
Start: 07/31/12 End: 01/31/13 Due: 01/31/14

Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing Vaso-Occlusive Crises Rate in Pediatric Patients With Sickle Cell Disease.

Phase: N/A Priority: Normal
NCT ID: NCT04293172 Org: User:
Start: 06/30/20 End: 10/10/22 Due: 10/10/23

Phase 1 PK Study of Cediranib in Single and Multiple Doses in Hepatically Impaired Patients With Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT00621725 Org: User:
Start: 01/31/08 End: 01/31/14 Due: 01/31/15

Association Between Low Dose Acetylsalicylic Acid (ASA) and Proton Pump Inhibitors and Risk of Acute Myocardial Infarction or Coronary Death

Phase: N/A Priority: Normal
NCT ID: NCT01360047 Org: User:
Start: 06/30/11 End: 12/31/11 Due: 12/31/12

Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT02051335 Org: User:
Start: 01/31/14 End: 05/31/14 Due: 05/31/15

Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolar Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01663974 Org: User:
Start: 04/30/13 End: 12/31/13 Due: 12/31/14

A Thorough QTC Study to Assess the Effect of Cotadutide on Cardiac Repolarization in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05668936 Org: User:
Start: 01/03/23 End: 03/10/23 Due: 03/10/24

C-PATROL - Non-interventional Study (NIS) to Collect Clinical and Patient Reported Outcome Data in an Olaparib Treated BRCAm+ PSR Ovarian Cancer Population

Phase: N/A Priority: Normal
NCT ID: NCT02503436 Org: User:
Start: 10/28/15 End: 12/01/22 Due: 12/01/23

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Phase: N/A Priority: Normal
NCT ID: NCT06137118 Org: User:
Start: 12/29/23 End: 05/18/27 Due: 05/18/28

A Study to Investigate Efficacy and Safety of Ceralasertib Plus Durvalumab in Participants Aged ≥ 18 Years With Advanced or Metastatic Non-small Cell Lung Cancer Whose Disease Progressed on or After Prior Anti-PD-(L)1 Therapy and Platinum-based Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT05941897 Org: User:
Start: 06/21/23 End: 07/29/25 Due: 07/29/26

Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT06824987 Org: User:
Start: 03/05/25 End: 08/30/27 Due: 08/30/28

A Study to Observe Real-life Allocation of Antipsychotics in Acute Inpatient Management of Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01394601 Org: User:
Start: 08/31/11 End: 12/31/11 Due: 12/31/12

Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)

Phase: N/A Priority: Normal
NCT ID: NCT04964934 Org: User:
Start: 06/30/21 End: 11/26/27 Due: 11/26/28

Open, Randomized, Two Way Crossover 40mg, Orally and Intravenously

Phase: N/A Priority: Normal
NCT ID: NCT00635414 Org: User:
Start: 08/31/02 End: 10/31/02 Due: 10/31/03

Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea

Phase: N/A Priority: Normal
NCT ID: NCT06998095 Org: User:
Start: 11/30/25 End: 10/31/29 Due: 10/31/30

Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02558894 Org: User:
Start: 11/16/15 End: 06/15/17 Due: 06/15/18

A Study in Healthy Volunteers to Assess Safety and Blood Levels of AZD9742 After Multiple Doses Over 14 Days

Phase: N/A Priority: Normal
NCT ID: NCT01064388 Org: User:
Start: 02/28/10 End: 08/31/10 Due: 08/31/11

Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.

Phase: N/A Priority: Normal
NCT ID: NCT01844986 Org: User:
Start: 08/26/13 End: 08/29/28 Due: 08/29/29

Non-interventional Study to Collect Real-world Clinical and Patient-reported Outcomes in Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04830709 Org: User:
Start: 06/15/21 End: 03/31/33 Due: 03/31/34

VITALIZE.Use and Effectiveness of Sodium Zirconium Cyclosilicate (LokelmaTM) in the Real-world Setting in Spain

Phase: N/A Priority: Normal
NCT ID: NCT06635499 Org: User:
Start: 11/13/24 End: 05/20/25 Due: 05/20/26

Non-alcoholic Steatohepatitis Registry Platform Study

Phase: N/A Priority: Normal
NCT ID: NCT06123858 Org: User:
Start: 11/22/23 End: 12/31/26 Due: 12/31/27

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06792695 Org: User:
Start: 03/12/25 End: 01/12/28 Due: 01/12/29

Ph II Study to Evaluate Olaparib With Abiraterone in Treating Metastatic Castration Resistant Prostate Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT01972217 Org: User:
Start: 04/01/14 End: 08/24/23 Due: 08/24/24